Your browser doesn't support javascript.
loading
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma.
Chen, Pei-Ling; Neishaboori, Nastaran; Tetzlaff, Michael T; Chen, Wei-Shen; Aung, Phyu P; Curry, Jonathan L; Nagarajan, Priyadharsini; Ivan, Doina; Hwu, Wen-Jen; Prieto, Victor G; Torres-Cabala, Carlos A.
Afiliação
  • Chen PL; Assistant Professor, Department of Cutaneous Oncology and Pathology, Moffitt Cancer Center, Tampa, FL.
  • Neishaboori N; Resident, Department of Pathology, Oregon Health and Science University, Portland, OR.
  • Tetzlaff MT; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chen WS; Assistant Professor, Department of Pathology, University of South Florida, Tampa, FL.
  • Aung PP; Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Curry JL; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nagarajan P; Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Ivan D; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hwu WJ; Professor, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Prieto VG; Professor, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Torres-Cabala CA; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Am J Dermatopathol ; 42(5): 313-321, 2020 May.
Article em En | MEDLINE | ID: mdl-32310893
ABSTRACT
The family of blue nevi includes the common blue nevus (BN), cellular blue nevus (CBN), and atypical BN, while melanomas with BN-like morphology can either arise in association with a blue nevus (MABN) or in the de novo setting mimicking cellular blue nevus (MMCBN). Recent molecular and immunohistochemical studies have demonstrated loss of BAP-1 in MABN/MMCBN but not in BN/CBN, suggesting that loss of BAP-1 correlates with a malignant phenotype in these lesions. In this study, we applied anti-BAP-1 antibodies to a series of CBN/BN (n = 11) and MABN/MMCBN (n = 4). Nuclear BAP-1 expression was detected in the majority of CBN/BN (n = 10/11) but was lost in 1 case. Most cases of MABN/MMCBN showed loss of nuclear BAP-1 expression (n = 3/4), with one case of MMCBN showing preserved BAP-1 expression. Demonstration of BAP-1 loss in a single case of CBN and preservation of BAP-1 expression in 1 case of MMCBN may indicate that detection of alterations in BAP-1 protein expression by immunohistochemistry may not be a completely reliable biomarker for the distinction of BN/CBN from MABN/MMCBN. Further investigation of the significance of BAP-1 loss/preservation in BN-like tumors is warranted.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo Azul / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase / Melanoma Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Am J Dermatopathol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo Azul / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase / Melanoma Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Am J Dermatopathol Ano de publicação: 2020 Tipo de documento: Article